# Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma

> **NCT00986037** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 47 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ABT-308
- **DRUG:** ABT-308
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00986037
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2017-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986037, "Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00986037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*